William Hait

JNJ

William Hait serves as See Remarks at Johnson & Johnson (JNJ). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$2.53M

Net Position

Net Seller

$2.53M

Companies Traded

JNJ

Active Period

Jul 2023

1 total trades

Most Recent

Sell JNJ

Jul 27, 2023 · $2.53M

William Hait's Insider Trading at Johnson & Johnson (JNJ)

Buys

0 · $0.00

Sells

1 · $2.53M

Total Shares Bought

Total Shares Sold

14,698

JNJ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 27, 2023	Sell	14,698	$172.00	$2.53M	87,747

Related Insiders

Robert J Decker

VP Corporate Controller

JNJSell · Mar 3, 2026

Timothy Schmid

EVP, WW Chair, MedTech

JNJSell · Feb 20, 2026

Kathryn E Wengel

EVP, Chief TO and Risk Officer

JNJSell · Feb 18, 2026

REED JOHN C

EVP, Innovative Medicine, R&D

JNJSell · Feb 15, 2026

Joseph J Wolk

Exec VP, CFO

JNJSell · Feb 13, 2026

Joaquin Duato

director, officer: CEO and Chairman of the Board

JNJSell · Feb 13, 2026

Elizabeth Forminard

Executive VP, General Counsel

JNJSell · Feb 13, 2026

Kristen Mulholland

EVP, Chief HR Officer

JNJSell · Feb 13, 2026

Explore More Insider Trading Data

JNJ Insider Trading Activity

View all insider trades at Johnson & Johnson

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity